|Videos|October 20, 2014
The Mechanism of Action of Trastuzumab
Author(s)Ruth M. O’Regan, MD
Ruth M. O’Regan, MD, director, Translational Breast Cancer Research, professor, hematology and oncology, medical oncology, Winship Cancer Institute, Emory University, discusses the mechanism of action of trastuzumab.
Advertisement
Clinical Pearls
Ruth M. O’Regan, MD, director, Translational Breast Cancer Research, professor, hematology and oncology, medical oncology, Winship Cancer Institute, Emory University, discusses the mechanism of action of trastuzumab.
- Trastuzumab has an effect on phosphorylation cascades that drive cancers, but that is not believed to be its main mechanism of action. Its effect on the immune system seems to be important.
- There is a need for a better understanding of trastuzumab’s resistance mechanisms.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Rethinking Advanced Prostate Cancer: Surprising Finds from a Landmark Study
2
Long-Term Follow-Up Confirms Benefits of Low-Dose Seminoma Treatment
3
FDA Accepts NDA for 177Lu-edotreotide in GEP-NETs
4
FDA Authorizes EXENT System to Aid Myeloma Diagnosis
5
